Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Arcaini

Showing results (71-80 of 262) with videos related to

Pageof 27
Sort By:
Hematological Oncology|July 28, 2021
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosisChiara Trotti, Emanuela Sant'Antonio, Daniele Vanni, et al.
Leukemia & Lymphoma|February 15, 2021
Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHNArturo Bonometti, Emanuela Boveri, Marzia Varettoni, et al.
Human Pathology|February 22, 2011
CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single caseMarco Lucioni, Francesca Novara, Roberta Riboni, et al.
British Journal of Haematology|November 22, 2007
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlationsEmanuela Boveri, Francesco Passamonti, Elisa Rumi, et al.
American Journal of Hematology|May 16, 2015
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndromeMarzia Varettoni, Enrico Marchioni, Maurizio Bonfichi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1Marco Lucioni, Marta Nicola, Roberta Riboni, et al.
Hemasphere|May 26, 2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert PanelPier Luigi Zinzani, Marco Paulli, Luca Arcaini, et al.
Cancer|September 26, 2006
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disordersElisa Rumi, Francesco Passamonti, Daniela Pietra, et al.
Cancer|July 28, 2005
Leukemic transformation of polycythemia vera: a single center study of 23 patientsFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
Leukemia & Lymphoma|February 28, 2013
Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptorsMarzia Varettoni, Silvia Zibellini, Daniela Capello, et al.
Pageof 27

Showing results (71-80 of 262) with videos related to

Sort By:
Pageof 27
Hematological Oncology|July 28, 2021
Acquired von Willebrand syndrome in myeloproliferative neoplasms with extreme thrombocytosisChiara Trotti, Emanuela Sant'Antonio, Daniele Vanni, et al.
Leukemia & Lymphoma|February 15, 2021
Systemic mastocytosis and lymphoplasmacytic lymphoma: an unusual and intriguing form of SM-AHNArturo Bonometti, Emanuela Boveri, Marzia Varettoni, et al.
Human Pathology|February 22, 2011
CD5(-) diffuse large B-cell lymphoma with peculiar cyclin D1+ phenotype. Pathologic and molecular characterization of a single caseMarco Lucioni, Francesca Novara, Roberta Riboni, et al.
British Journal of Haematology|November 22, 2007
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlationsEmanuela Boveri, Francesco Passamonti, Elisa Rumi, et al.
American Journal of Hematology|May 16, 2015
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndromeMarzia Varettoni, Enrico Marchioni, Maurizio Bonfichi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1Marco Lucioni, Marta Nicola, Roberta Riboni, et al.
Hemasphere|May 26, 2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert PanelPier Luigi Zinzani, Marco Paulli, Luca Arcaini, et al.
Cancer|September 26, 2006
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disordersElisa Rumi, Francesco Passamonti, Daniela Pietra, et al.
Cancer|July 28, 2005
Leukemic transformation of polycythemia vera: a single center study of 23 patientsFrancesco Passamonti, Elisa Rumi, Luca Arcaini, et al.
Leukemia & Lymphoma|February 28, 2013
Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptorsMarzia Varettoni, Silvia Zibellini, Daniela Capello, et al.
Pageof 27